Play Video
The so-called CAR-T cells are powerful new tools for treating cancer that are created by genetically modifying a person’s existing T-cells. These T-cells are being used to target CD19, a protein marker found on all cells in patients with leukemia and lymphoma. “Over the next several years, B.C. Cancer’s CAR-T cell program will expand beyond leukemia and lymphoma to create new and improved treatments for a wide spectrum of cancers” saidThis advertisement has not loaded yet, but your article continues below.“The Deeley Research Centre in Victoria is a world pioneer in immunotherapy, harnessing the body’s own immune system to prevent, control and eliminate cancer — and has already revolutionized cancer care,” said Sarah Roth, CEO of the B.C.